[Frontiers in Bioscience 2, d207-221, May 1, 1997]

Table of Conents
 Previous Section   Next Section


Chun Kung and Matthew L. Thomas

Department of Pathology, HHMI, Washington University, 660 S. Euclid Avenue, St. Louis, MO 63110

Received 4/4/97; Accepted 4/24/97; On-line 5/1/97


1. L. M. L. Chow & A. Veillette: The Src and Csk families of tyrosine protein kinases in hemopoietic cells. Semin Immunol 7, 207-226 (1995)

2. G. Zenner, J. D. zur Hansen, P. Burn & T. Mustelin: Towards unraveling the complexity of T cell signal transduction. BioEssays 17, 967-975 (1995)

3. M. Szamel & K. Resch: T-cell antigen receptor-induced signal-transduction pathways - activation and function of protein kinases C in T lymphocytes. Eur J Biochem 228, 1-15 (1995)

4. L. B. Justement, V. K. Brown & J. Lin: Regulation of B cell activation by CD45: a question of mechanism. Immunol Today 15, 399-406 (1994)

5. A. Weiss & D. R. Littman: Signal transduction by lymphocyte antigen receptors. Cell 76, 263-274 (1994)

6. A. C. Chan & A. S. Shaw: Regulation of antigen receptor signal transduction by protein tyrosine kinases. Curr Opin Immunol 8, 394-401 (1995)

7. R. L. Wange, R. Guitan, N. Isakov, J. D. Watts, R. Aebersold & L. E. Samelson: Activating and inhibitory mutations in adjacent tyrosines in the kinase domain of ZAP-70. J Biol Chem 270, 18730-18733 (1995)

8. A. C. Chan, M. Dalton, R. Johnson, G. H. Kong, T. Wang, R. Thoma & T. Kunoshi: Activation of ZAP-70 kinase activity by phosphorylation of tyrosine 493 is required for lymphocyte antigen receptor function. EMBO J 14, 2499-2508 (1995)

9. D. Mege, V. Di Bartolo, V. Germain, L. Tuosto, F. Michel & O. Acuto: Mutation of tyrosines 492/493 in the kinase domain of ZAP-70 affects multiple T-cell receptor signaling pathways. J Biol Chem 271, 32644-32652 (1996)

10. E. Cano & L. C. Mahadevan: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20, 117-122 (1995)

11. C. J. Marshall: Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80, 179-185 (1995)

12. K. S. Ravichandran, K. K. Lee, Z. Songyang, L. C. Cantley, P. Burn & S. J. Burakoff: Interaction of Shc with the zeta chain of the T cell receptor upon T cell activation. Science 262, 902-905 (1993)

13. M. Deckert, S. Tartare-Deckert, C. Couture, T. Mustelin & A. Altman: Functional and physical interactions of Syk kinases with the Vav proto-oncogene product. Immunity 5, 591-604 (1996)

14. P. Crespo, K. E. Schuebel, A. A. Ostrom, J. S. Gutkind & X. R. Bustelo: Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385, 169-172 (1997)

15. P. Crespo, X. R. Bustelo, D. S. Aaronson, O. A. Coso, M. Lopez-Barahona, M. Barbacid & J. S. Gutkind: Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. Oncogene 13, 455-460 (1996)

16. R. G. Qiu, J. Chen, D. Kim, F. McCormick & M. Symons: An essential role for Rac in Ras transformation. Nature 374, 457-459 (1995)

17. R. G. Qiu, J. Chen, F. McCormick & F. Symons: A role for Rho in Ras transformation. Proc Natl Acad Sci USA 92, 11781-11785 (1995)

18. J. Wu, S. Katzov & A. Weiss: A functional T-cell receptor signaling pathway is required for p95vav activity. Mol Cell Biol 15, 4337-4346 (1995)

19. E. Genot, S. Cleverley, S. Henning & D. Cantrell: Multiple p21ras effector pathways regulate nuclear factor of activated T cells. EMBO J 15, 3923-3933 (1996)

20. K. Nagai, M. Takata, H. Yamamura & T. Kurosaki: Tyrosine phosphorylation of Shc is mediated through Lyn and Syk in B cell receptor signaling. J Biol Chem 270, 6824-6829 (1995)

21. J. B. Wardenburg, C. Fu, J. K. Jackman, H. Flotow, S.E. Wilkinson, D.H. Williams, R. Johnson, G. Kong, A.C. Chan & P.R. Findell: Phosphorylation of SLP-76 by the ZAP-70 protein tyrosine kinase is required for T-cell receptor function. J Biol Chem 271, 19641-19644 (1996)

22. Y-C. Liu, C. Elly, W. Y. Langdon & A. Altman: Ras-dependent, Ca2+-stimulated activation of nuclear factor of activated T cells by a constitutively active Cbl mutant in T cells. J Biol Chem 272, 168-173 (1997)

23. A. Y. Tsygankov, M. Mahajan, J. E. Fincke & J. B. Bolen: Specific association of tyrosine-phosphorylated c-Cbl with Fyn tyrosine kinase in T cells. J Biol Chem 271, 27130-27137 (1996)

24. S. M. Anderson, E. A. Burton & B. L. Koch: Phosphorylation of Cbl following stimulation with interleukin-3 and its association with Grb-2, Fyn and phosphatidylinositol 3-kinase. J Biol Chem 272, 739-745 (1997)

25. T. Tezuka, H. Umemori, N. Fusaki, T. Yagi, M. Takata, T. Kurosaki & T. Yamamoto: Physical and functional association of the cbl protooncogene product with an src-family protein tyrosine kinase, p53/56lyn, in the B cell antigen receptor-mediated signaling. J Exp Med 183, 675-80 (1996)

26. R. J. Ingham, D. L. Kreb, S. M. Barbazuk, C. W. Turck, H. Hirai, M. Matsuda & M. R. Gold: B cell antigen receptor signaling induces the formation of complexes containing the Crk adapter proteins. J Cell Biol 271, 32306-32314 (1996)

27. M. Takata, H. Sabe, A. Hata, T. Inazu, Y. Homma, T. Nukada, H. Yamamura & T. Kurosaki: Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J 13, 1341-1349 (1994)

28. M. Takata & T. Kurosaki: A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2. J Exp Med 184, 31-40 (1996)

29. A. L. Sillman & J. G. Monroe: Association of p72syk with the src homology-2 (SH2) domains of PLC gamma 1 in B lymphocytes. J Biol Chem 270, 11806-11811 (1995)

30. H. Yamaguichi & W. A. Hendrickson: Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature 384, 484-489 (1996)

31. F. Sicheri, I. Moarefi & J. Kuriyan: Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609 (1997)

32. W. Xu, S. C. Harrison & M. J. Eck: Three-dimensional structure of the tyrosine kinase c-Src. Nature 385, 595-602 (1997)

33. J-F. Cloutier, L. M. Chow & A. Veilette: Requirement of the SH3 and SH2 domains for the inhibitory function of tyrosine protein kinase p50csk in T lymphocytes. Mol Cell Biol 15, 5937-5944 (1995)

34. L. M. Chow, C. Jarvis, Q. Hu, S. H. Nye, F. G. Gervais, A. Veilette & L. A. Matis: Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T-lymphocytes. Proc Natl Acad Sci USA 91, 4975-4979 (1994)

35. A. Imamoto & P. Soriano: Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73, 1117-1124 (1993)

36. S. Nada, T. Yagi, H. Takeda, T. Tokunaga, H. Nakagawa, Y. Ikawa, M. Okada & S. Aizawa: Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73, 1125-1135 (1993)

37. M. Autero, J. Saharinen, T. Pessa-Morikawa, M. Soula-Rothhut, C. Oetken, M. Gassmann, M. Bergman, K. Alitalo, P. Burn, C.G. Gahmberg & T. Mustelin: Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56csk tyrosine kinase and activates the phosphatase. Mol Cell Biol 14, 1308-1321 (1994)

38. U. D'oro, K. Sakaguichi, E. Apella & J. D. Ashwell: Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol Cell Biol 16, 4996-5003 (1996)

39. W. Rodgers & J. K. Rose: Exclusion of CD45 inhibits activity of p56csk associated with glycolipid-enriched membrane domains. J Cell Biol 135, 1515-1523 (1996)

40. D. R. Plas, R. Johnson, J. T. Pingel, R. J. Matthews, M. Dalton, G. Roy, A. C. Chan & M. L. Thomas: Direct regulation of ZAP-70 by SHP-1 in T cell antigen receptor signaling. Science 272, 1173-1176 (1996)

41. U. Lorenz, K. S. Ravichandran, S. J. Burakoff & B. G. Neel: Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyper-responsiveness. Proc Natl Acad Sci USA 93, 9624-9629 (1996)

42. G. Doody, L. Justement, C. Delibrais, R. Matthews, J. Lin, M. Thomas & D. Fearon: A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269, 242-244 (1995)

43. D. D'Ambrosio, K. L. Hippen, S. A. Minskoff, I. Mellman, G. Pani, K. A. Siminovitch & J. C. Cambier: Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcgammaRIIB1. Science 268, 293-296 (1995)

44. L. A. Conroy & D. R. Alexander: The role of intracellular signaling pathways regulating thymocyte development and leukemic T cell apoptosis. Leukemia 10, 1422-1435 (1996)

45. F. Melchers, A. Rolink, U. Grawunder, T. H. Winkler, H. Karasuyama, P. Ghia & J. Andersson: Positive and negative selection events during B lymphopoiesis. Curr Opin Immunol 7, 214-227 (1995)

46. T. J. Molina, K. Kishihara, D. P. Siderovski, W. van Ewijk, A. Narendran, E. Timms, A. Wakeham, C. J. Paige, K. U. Hartmann, A. Veillette, D. Davidson & T. W. Mak : Profound block in thymocyte development in mice lacking p56csk. Nature 357, 161-164 (1992)

47. M. W. Appleby, J. A. Gross, M. P. Cooke, S. D. Levin, X. Qian & R. M. Perlmutter: Defective T cell receptor signaling in mice lacking the thymic isoform of p59csk. Cell 70, 751-763 (1992)

48. P. L. Stein, H-M. Lee, S. Rich & P. Soriano: pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 70, 741-750 (1992)

49. T. Groves, P. Smiley, M. P. Cooke, K. Forbush, R. M. Perlmutter & C. J. Guidos: Fyn can partially substitute for Lck in T lymphocyte development. Immunity 5, 417-428 (1996)

50. N. S. C. van Oers, B. Lowin-Kropf, D. Finlay, K. Connolly & A. Weiss: alphabeta T cell development is abolished in mice lacking both Lck and Fyn protein tyrosine kinases. Immunity 5, 429-436 (1996)

51. P. Mombaerts, S. J. Anderson, R. M. Perlmutter, T. W. Mak & S. Tonegawa: An activated lck transgene promotes thymocyte development in RAG-1 mutant mice. Immunity 1, 261-267 (1994)

52. M. P. Cooke, K. M. Abraham, K. A. Forbush & R. M. Perlmutter: Regulation of T cell receptor signaling by a src family protein-tyrosine kinase (p59csk). Cell 65, 281-291 (1991)

53. S. J. Anderson, S. D. Levin & R. M. Perlmutter: Protein tyrosine kinase p56csk controls allelic exclusion of T cell receptor beta chain genes. Nature 365, 552-554 (1993)

54. S. Levin, S. Anderson, K. Forbush & R. Perlmutter: A dominant-negative transgene defines a role for p56csk in thymopoiesis. EMBO J 12, 1671-1680 (1993)

55. K. Hashimoto, S. J. Soln, S. D. Levin, T. Tada, R. M. Perlmutter & T. Nakayama: Requirement for p56csk tyrosine kinase activation in T cell receptor-mediated thymic selection. J Exp Med 184, 931-943 (1996)

56. A. K. Tarakhovsky, S. B. Kanner, J. Hombach, J. A. Ledbetter, W. Muller, N. Killeen & K. Rajewsky: A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269, 535-537 (1995)

57. G. Bikah, J. Carey, J. R. Ciallella, A. Tarakhovsky & S. Bondada: CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 274, 1906-1909 (1996)

58. D. L. Wiest, J. M. Ashe, R. Abe, J. B. Bolen & A. Singer: TCR activation of ZAP-70 is impaired in CD4+ CD8+ thymocytes as a consequence of intrathymic interactions that diminish available p56csk. Immunity 4, 495-504 (1996)

59. M. L. Hibbs, D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker & A. R. Dunn: Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311 (1995)

60. A. C. Chan, T. A. Kadlecek, M. E. Elder, A. H. Filipovich, W. L. Kuo, M. Iwashima, T. G. Parslow & A. Weiss: ZAP-70 deficiency in an autosomal recessive form of severe combined immunodeficiency. Science 264, 1599-1601 (1994)

61. M. E. Elder, D. Lin, J. Clever, A. C. Chan, T. J. Hope, A. Weiss & T. G. Parslow: Human severe combined immnuodeficiencies are due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264, 1596-1599 (1994)

62. E. Arpaia, M. Shahar, H. Dadi, A. Cohen & C. M. Roifman: Defective T cell receptor signaling and CD8+ thymic selection in humans lacking ZAP-70 kinase. Cell 76, 947-958 (1994)

63. I. Negishi, N. Motoyama, K. Nakayawa, K. Nakayama, S. Senju, S. Hatakeyama,Q. Zhang, A. C. Chan & D. Y. Loh: Essential role for ZAP-70 in both positive and negative selection of thymocytes. Nature 376, 435-438 (1995)

64. M. Turner, P. J. Mee, P. S. Costello, O. Williams, A. A. Price, L. P. Duddy, M. T. Furlong, R. L. Geahlen & V. L. Tybulewicz: Perinatal lethality and blocked T cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302 (1995)

65. A. M. Cheng, B. Rowley, W. Pao, A. Hayday, J. B. Bolen & T. Pawson: Syk tyrosine kinase required for mouse viability and B cell development. Nature 378, 303-306 (1995)

66. M. Takata, H. Sabe, H. Hata, T. Inazu, Y. Homma, T. Nukada, H.Yamamura & T. Kurosaki: Tyrosine kinase Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J 13, 1341-1349 (1994)

67. C. A. Mallick-Wood, W. Pao, A. M. Cheng, J. M. Lewis, S. Kulkarni, J. B. Bolen, B. Rowley, R. E. Tigelaar , T. Pawson & A. C. Hayday: Disruption of epithelial gammadelta T cell repertoires by mutations of the Syk tyrosine kinase. Proc Natl Acad Sci USA 93, 9704-9709 (1996)

68. A. C. Chan, N. S. C. van Oers, A. Tran, L. Turka, C. L. Law, J. C. Ryan, E. A. Clark & A. Weiss: Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. J Immunol 152, 4758-4766 (1994)

69. G. H. Kong, J. Y. Bu, T. Kurosaki, A. S. Shaw & A. C. Chan: Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. Immunity 2, 485-492 (1995)

70. G. Roy, J. Matthews, T. Woodford-Thomas & M. L. Thomas: The function of protein tyrosine phosphatases in immune regulation. Adv Prot Phosphatases 9, 121-138 (1995)

71. M. Okumura & M. L. Thomas: Regulation of immune function by protein tyrosine phosphatases. Curr Opin Immunol 7, 312-319 (1995)

72. M. L. Thomas: Positive and negative regulation of leukocyte activation by protein tyrosine phosphatases. Semin Immunol 7, 279-288 (1995)

73. J. A. R. Frearson & D Alexander: Protein tyrosine phosphatases in T-cell development, apoptosis and signaling. Immunol Today 17, 385-391 (1996)

74. C. M. Burns, K. Sakaguichi, E. Appella & J. D. Ashwell: CD45 regulation of tyrosine phosphorylation and enzyme activity of of the src family kinase. J Biol Chem 269, 13594-13600 (1994)

75. T. R. Hurley, R. Hyman & B. M. Sefton: Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphatase of the Lck, Fyn, c-Src tyrosine kinases. Mol Cell Biol 18,1651-1656 (1993)

76. E. D. McFarland, T. R. Hurley, J. Pingel, J. T. Sefton, A. Shaw & M. L. Thomas: Correlation between Src family member regulation by the protein-tyrosine-phosphatase CD45 and transmembrane signaling through the T-cell receptor. Proc Natl Acad Sci USA 90, 1402-1406 (1993)

77. M. Sieh, J. B. Bolen & A. Weiss: CD45 specifically modulates binding of Lck to a phosphopeptide encompassing the negative regulatory tyrosine of Lck. EMBO J 12, 315-322 (1993)

78. F. G. Gervais & A. Veillette: The unique amino-terminal domain of p56csk regulates interactions with protein tyrosine phosphatases inT-lymphocytes. Mol Cell Biol 15, 2393-2401 (1995)

79. S. Yanagi, H. Sugawara, M. Kurosaki, H. Sabe, H. Yamamura & T. Kurosaki: CD45 modulates phosphorylation of both autophosphorylation and negative regulatory tyrosines of Lyn in B cells. J Biol Chem 271, 30487-30492 (1996)

80. A. Hata, H. Sabe, T. Kurosaki, M. Takata, & H. Hanafusa: Functional analysis of Csk in signal transduction through the B-cell antigen receptor. Mol Cell Biol 14, 7306-7313 (1994)

81. S. Volarevic, B. B. Niklinska, C. M. Burns, C H. June, A. M. Weisman & J. D. Ashwell: Regulation of TCR signaling by CD45 lacking transmembrane and extracellular domains. Science 260, 541-543 (1993)

82. R. R. Hovis, J. A. Donovan, M. A. Musci, D. G. Motto, F. D. Goldman, S. E. Ross & G. A. Koretzky: Rescue of signaling by a chimeric protein containing the cytoplasmic domain of CD45. Science 260, 544-546 (1993)

83. D. Chu, C. J. Ong, P. Johnson, H-S. Teh & J. D. Marth: Specific CD45 isoforms differentially regulate T cell receptor signaling. EMBO J 13, 798-807 (1994)

84. T. J. Novak, D. Farber, D. Leitenburg, S-C. Hong, P. Johnson & K. Bottomly: Isoforms of the transmembrane tyrosine phosphatase CD45 differentially affect T cell recognition. Immunity 1, 109-119 (1994)

85. D. W. Mckenney, H. Onodera, L. Gorman, T. Mimura & D. M. Rothstein: Distinct isoforms of the CD45 protein-tyrosine phosphatase differentially regulate interleukin 2 secretion and activation signal pathways involving Vav in T cells. J Biol Chem 270, 24949-24954 (1995)

86. H. Onodera, D. G. Motto, G. A. Koretzky & D. M. Rothstein: Differential regulation of activation-induced tyrosine phosphorylation and recruitment of SLP-76 to Vav by distinct isoforms of the CD45 protein-tyrosine phosphatase. J Biol Chem 271, 22225-22230 (1996)

87. L. I. Pao, W. D. Bedzyk, C. Persin & J. C. Cambier: Molecular targets of CD45 in B cell antigen receptor signal transduction. J Immunol 158, 1116-1124 (1997)

88. A. D. Beyers, L. L. Spruyt & A. F. Williams: Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4 or CD8 and CD5. Proc Natl Acad Sci USA 89, 2945-2949 (1992)

89. F. D. Howard, P. Moingeon, U. Moebius, D. J. McConkey, B. Yandava, T. E. Gennert & E. L. Reinherz: The CD3 zeta cytoplasmic domain mediates CD2-induced T cell activation. J Exp Med 176, 139-145 (1992)

90. P. Moingeon, J. L. Lucich, D. J. McConkey, F. Letourneur, B. Malissen, J. Kochan, H. C. Chang, H. R. Rodewald & E. L. Reinherz: CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells. Proc Natl Acad Sci USA 89, 1492-1496 (1992)

91. A. M. Caruso, D. W. Mason & A. D. Beyers: Physical association of the cytoplasmic domain of CD2 with the tyrosine kinases p56lck and p59fyn. Eur J Immunol 23, 2196-2201 (1993)

92. M. Gassmann, K. E. Amrein, N. A. Flint, B. Schraven & P. Burn: Identification of a signaling complex involving CD2, zeta chain and p59fyn in T lymphocytes. Eur J Immunol 24, 139-144 (1994)

93. A. M. Verhagen, B. Schraven, M. Wild, R. Wallich & S. C. Meuer: Differential interaction of the CD2 extracellular and intracellular domains with the tyrosine phosphatase CD45 and the zeta chain of the TCR/CD3/zeta complex. Eur J Immunol 26, 2841-2849 (1996)

94. D. Leitenburg, T. J. Novak, D. Farber, B. R. Smith & K. Bottomly: The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation. J Exp Med 183, 249-259 (1996)

95. T. Benatar, R. Carsetti, C. Furlonger, N. Kamalia, T. Mak & C. J. Paige: Immunoglobin-mediated signal transduction in B cells from CD45-deficient mice. J Exp Med 183, 329-334 (1996)

96. K. Kishihara, J. Penninger, V. A. Wallace et al.: Normal B lymphocyte development but impaired T cell maturation in CD45-exon 6 protein tyrosine phosphatase-deficient mice. Cell 74, 143-156 (1993)

97. J. G. Cyster, J. I. Healy, K. Kishihara, T. W. Mak, M. L. Thomas & C. C. Goodnow: Regulation of B-lymphocyte negative and positive selection by tyrosine phosphophatase CD45. Nature 381, 325-328 (1996)

98. K. F. Byth, L. A. Conroy, S. Howlett, A. J. H. Smith, J. May, D. R. Alexander & N. Holmes: CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+ CD8+ thymocytes and in B cell maturation. J Exp Med 183, 1707-1718 (1996)

99. J. Kirburg & T. Brocker: CD45 up-regulation during lymphocyte maturation. Intl Immunol 8, 1743-1749 (1996)

100. A. Takeda, J. J. Wu & A. L. Maizel: Evidence for a monomeric and dimeric forms of CD45 associated with a 30kDa phosphorylated protein. J Biol Chem 16651-16639 (1993)

101. A. M. Bilwes, J. den Hertog, T. Hunter & J. P. Noel: Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. Nature 382, 555-559 (1995)

102. M. L. Dustin & T. A. Springer: T cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341, 619-624 (1989)

103. F. Spertini, A. V. Wang, T. Chatila & R. S. Geha: Engagement of the common leukocyte antigen CD45 induces homotypic adhesion of activated human T cells. J Immunol 153, 1593-1602 (1994)

104. J. M. Zapata, M. R. Campanero, M. Marazeula, F. Sanchez-Madrid & M. O. de Landazuri: B-cell homotypic adhesion through exon A restricted epitopes of CD45 involves LFA-1/ICAM-1, ICAM-3 interactions, and induces coclustering of CD45 and LFA-1. Blood 86, 1861-1872 (1995)

105. A. G. Arroyo, M. R. Campanero, P. Sanchez-Mateos, J. M. Zapata, M. A. Ursa, M. A. del Pozo & F. Sanchez-Madrid: Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase. J Cell Biol 126, 1277-1286 (1994)

106. C. Herold, A. Elhabazi, G. Bismuth, A. Bensussan & L. Boumsell: CD100 is associated with CD45 at the surface of human T lymphocytes- role in T cell homotypic adhesion. J Immunol 157, 5262-5268 (1996)

107. E. D. Cahir McFarland, & M. L. Thomas: CD45 protein-tyrosine phosphatase associates with the WW domain-containing protein, CD45AP, through the transmembrane region. J Biol Chem 270, 28103-28107 (1995)

108. E. Bruyns, L. R. Hendrickson-Taylor, S. Meuer, G. A. Koretzky & B. Schraven: Identification of the sites of interaction between LPAP and CD45. J Biol Chem 270, 3132-31378 (1995)

109. K. A. Kitamura, A. Maita, D. H. W. Ng, P. Johnson, A. L. Maizel & A. Takeda: Characterization of interactions between CD45 and CD45AP. J Biol Chem 270, 21151-21154 (1995)

110. D. M. Desai, J. Sap, I. Schlessinger & A. Weiss: Ligand mediated negative regulation of a chimeric transmembrane receptor tyrosine phospatase. Cell 73, 541-554 (1994)

111. B. Schraven, D. Schoenhaut, E. Bruyns, G. Koretzky, C. Eckerskorn, R. Wallich, H. Kirchgessner, P. Sakorafas, B. Labkovsky, S. Ratnofsky & S. Meuer: LPAP, a novel 32-kDa phosphoprotein that interacts with CD45 in human lymphocytes. J Biol Chem 269, 29102-29111 (1994)

112. D. C. Chan, M. T. Bedford & P. Leder: Formin binding proteins bear WWP/WW domains that bind proline-rich peptides and functionally resemble SH3 domains. EMBO J 15, 1045-1054 (1996)